Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
150.33
-17.16 (-10.25%)
At close: Aug 6, 2025, 4:00 PM
150.33
0.00 (0.00%)
After-hours: Aug 6, 2025, 7:00 PM EDT
Splunk Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$200,429
Profits / Employee
-$3,444
Market Cap
7.38B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRL News
- 5 hours ago - Charles River Laboratories International, Inc. (CRL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 hours ago - Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing - Benzinga
- 6 hours ago - Charles River: Margin Fears Outweigh Solid Q2 - Seeking Alpha
- 11 hours ago - Charles River raises profit forecast on growing demand for drug development services - Reuters
- 12 hours ago - Charles River Laboratories Announces Second-Quarter 2025 Results - Business Wire
- 15 days ago - Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development - Business Wire
- 22 days ago - Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call - Business Wire
- 7 weeks ago - Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment - Business Wire